Abstract
This paper examines whether the COVID-19-induced employment shocks have increased suicides and safety net use in the second and third quarters of 2020. We exploit plausibly exogenous regional variation in the magnitude of the employment shocks in Japan and adopt a difference-in-differences research design to identify the employment-shock impact. Our preferred point estimates suggest that a one-percentage-point increase in the unemployment rate in the second quarter of 2020 resulted in, approximately, an additional 0.39 suicides, 89 and 82 recipients of two temporary loan programs, 28 recipients of the Housing Security Benefit, and 11 recipients of Public Assistance per 100,000 population per month. A simple back-of-the-envelope calculation based on the estimate suggests that if Japan experienced a one-percentage-point increase in the unemployment rate caused by the COVID-19 crisis in the second quarter (i.e., April to June) in 2020, which is roughly equivalent to the third-highest employment shock at the regional level, this could have led to an additional 495 suicides in July 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JSPS KAKENHI Grant Number JP20K01733.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB and ethics committee approvals are required for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data and graphs presented in the paper will be available at https://github.com/michihito-ando.